CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, Silvano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.298
EU - Europa 25.362
AS - Asia 16.878
SA - Sud America 2.024
AF - Africa 368
Continente sconosciuto - Info sul continente non disponibili 300
OC - Oceania 29
Totale 79.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.968
GB - Regno Unito 8.807
SG - Singapore 7.505
RU - Federazione Russa 6.744
CN - Cina 4.754
IT - Italia 1.809
DE - Germania 1.678
BR - Brasile 1.639
FR - Francia 1.482
SE - Svezia 1.420
VN - Vietnam 1.357
HK - Hong Kong 1.349
FI - Finlandia 1.254
IE - Irlanda 1.100
KR - Corea 577
UA - Ucraina 540
TR - Turchia 258
BD - Bangladesh 242
NG - Nigeria 191
IN - India 170
JP - Giappone 163
CA - Canada 144
AR - Argentina 131
MX - Messico 103
NL - Olanda 93
IQ - Iraq 89
BE - Belgio 80
EC - Ecuador 76
ID - Indonesia 67
ES - Italia 61
PL - Polonia 61
ZA - Sudafrica 57
CL - Cile 46
AT - Austria 42
IR - Iran 37
PK - Pakistan 37
UZ - Uzbekistan 35
CO - Colombia 34
VE - Venezuela 32
IL - Israele 31
CZ - Repubblica Ceca 28
SA - Arabia Saudita 27
MA - Marocco 25
AU - Australia 23
KE - Kenya 23
PY - Paraguay 23
JM - Giamaica 21
PE - Perù 21
EG - Egitto 20
NP - Nepal 20
PH - Filippine 20
LT - Lituania 18
BG - Bulgaria 15
CH - Svizzera 15
AE - Emirati Arabi Uniti 14
JO - Giordania 14
RO - Romania 14
TN - Tunisia 14
CR - Costa Rica 13
UY - Uruguay 13
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
MY - Malesia 11
AL - Albania 10
DZ - Algeria 9
KG - Kirghizistan 9
LV - Lettonia 9
SK - Slovacchia (Repubblica Slovacca) 9
BO - Bolivia 8
HU - Ungheria 8
QA - Qatar 8
HR - Croazia 7
NO - Norvegia 7
OM - Oman 7
PS - Palestinian Territory 7
PT - Portogallo 7
SV - El Salvador 7
TH - Thailandia 7
TW - Taiwan 7
A2 - ???statistics.table.value.countryCode.A2??? 6
GE - Georgia 6
GR - Grecia 6
KZ - Kazakistan 6
MD - Moldavia 6
NZ - Nuova Zelanda 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
RS - Serbia 5
SN - Senegal 5
AM - Armenia 4
BB - Barbados 4
CM - Camerun 4
IS - Islanda 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
BY - Bielorussia 3
EE - Estonia 3
EU - Europa 3
Totale 78.902
Salva come PNG Salva come JPEG
Città #
Dallas 8.318
Southend 7.994
Jacksonville 4.339
Singapore 4.185
Chandler 2.545
Ashburn 2.250
San Jose 2.115
Woodbridge 2.089
Moscow 1.788
Ann Arbor 1.658
Hong Kong 1.331
Houston 1.192
Dublin 1.095
The Dalles 847
Verona 722
Beijing 579
Wilmington 552
Lawrence 538
Princeton 538
Ho Chi Minh City 437
Nanjing 428
Los Angeles 425
Jinan 395
New York 380
Shenyang 339
Buffalo 318
Hanoi 301
Council Bluffs 299
Helsinki 239
Boardman 232
Sindelfingen 232
Hebei 222
Milan 209
Abuja 188
Tianjin 186
Santa Clara 178
Changsha 165
Tokyo 144
São Paulo 139
Nanchang 135
Dong Ket 134
Columbus 126
Zhengzhou 123
Haikou 121
Jiaxing 113
Ningbo 113
Hangzhou 112
Guangzhou 111
Taizhou 100
Redondo Beach 92
Orem 88
Munich 85
Brussels 74
Falls Church 73
Taiyuan 71
Philadelphia 69
Norwalk 68
Frankfurt am Main 67
San Francisco 67
Chicago 63
Rio de Janeiro 59
Detroit 57
Fairfield 56
Rome 55
Lanzhou 54
Seattle 51
Warsaw 51
Amsterdam 50
Da Nang 50
Brooklyn 49
Chennai 49
Lancaster 47
London 47
Fuzhou 46
Bologna 45
Atlanta 44
Toronto 43
Denver 42
Phoenix 42
Washington 41
Dearborn 40
Turku 38
Belo Horizonte 37
Brasília 37
Düsseldorf 36
Haiphong 36
Mexico City 36
Paris 36
Redmond 35
Falkenstein 33
Orani 33
Boston 32
Montreal 32
Stockholm 31
Biên Hòa 30
Curitiba 30
Johannesburg 30
Nuremberg 30
Porto Alegre 30
Auburn Hills 29
Totale 53.785
Salva come PNG Salva come JPEG
Nome #
1,25-dihydroxy vitamin D in primary hyperparathyroidism 3.868
1,25 (OH) 2D3 stimulates and bisphosphonates inhibit fibronectin release by human microphages. 3.769
Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis 492
Teriparatide and denosumab combination therapy and skeletal metabolism 351
Artrite Reumatoide e Metabolismo Minerale 272
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 272
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 266
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 256
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 256
PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH GROUP A STREPTOCOCCAL INFECTION (PANDAS): CARDIAC AND ARTICULAR INVOLVEMENT 255
[Serum calcium evaluation and incidence of primary hyperparathyroidism in hospitalized patients (author's transl)] 252
[Incidence of thyroid diseases in primary hyperparathyroidism] 251
[Rational bases for the treatment of osteoporosis] 247
25-OH-D metabolism in primary hyperparathyroidism 247
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 246
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 245
12 month-retrospective analysis of two different rituximab retreatment regimens in rheumatoid arthritis:retreatment at clinical relapse Vs 6 (th) month fixed retreatment 245
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 245
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 240
[Acid-base balance in primary hyperparathyroidism] 239
Age-related bone loss in postmenopausal women 238
Il trattamento del morbo di Paget con calcitonina umana: influenza della secrezione paratoidea e dei titoli di anticorpi anti-calcitonina (umana e porcina) 234
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 234
[Therapeutic strategies in osteoporosis: whom and when to treat] 233
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 230
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 230
12 month-retrospective analysis of two different Rituximab pretreatment regimens in Rheumatoid Arthritis: retreatment at clinical relapse versus 6th month fixed pretreatment. 229
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 228
[Risk factors for hip fracture in elderly persons]. 224
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 223
[Studies on the therapeutic efficacy of a new diuretic combination in patients with edema of hepatic and cardiac etiology] 221
Effects of therapeutic doses of salbutamol alone and combined with beclomethasone dipropionate on airway responsiveness and cyclic AMP plasma levels in asthmatic patients 219
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 217
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 215
Analisi di linkage di geni candidati per densità minerale 213
[Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease] 211
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 210
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 209
[Pathophysiology of osteoarthritis: perspectives] 207
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 206
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 206
Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia 205
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 204
Bone involvement and osteoporosis in mastocytosis. 203
Incidenza di ipovitaminosi D nel Nord Italia 198
Power Doppler ultrasonographic findings in healthy pediatric entheses 198
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 198
Aberration in vitamin D metabolism during mianserin treatment [letter] 197
[Italian guidelines for the diagnosis and treatment of Paget's disease of bone]. 194
Prevalence and incidence of rheumatoid arthritis in Italy. 191
Serum thyroid hormone concentrations and weight loss relationships in eight obese women during semistarvation 190
Growth Hormone in Combination with Bisphosphonate Treatment in Osteogenesis Imperfecta. 190
Bone involvement in patient with clonal mast cell disorders 190
Primary hyperparathyroidism: diagnostic value of a model of multivariate statistical analysis 188
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 188
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 188
Antinuclear antibody profile in systemic sdclerosis patients who are negative for anticentromere and anti-topoisomerase I specificities 187
L'attività xantino-ossidasica epatocitaria nelle siderocromatosi primitive e secondarie 185
Valutazione ecografia con power doppler delle entesi in età pediatrica 185
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 185
Association between bone mineral density and serum lipid in men 184
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 184
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 184
[Ketotifen in the therapy of bronchial asthma] 182
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 182
Osteopetrosi 180
Allergy and the bone: unexpected relationships 179
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 179
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 178
Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin 178
Osteoporosis treatment: why ibandronic acid? 176
Sustained vertebral fracture risk reduction after withdrowal of teriparatide in postmenopausal women with osteoporosis 175
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. 175
Rapporti tra sistema immune e metabolismo osseo 174
Adverse effects of bisphosphonates. A comparative review 173
Digital Amputation in Systemic Sclerosis: Prevalence and Clinical Associations. A Retrospective Longitudinal Study. 173
Discriminant analysis in the differential diagnosis of hypercalcaemia 172
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 172
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 172
[Diacetylrhein in the treatment of degenerative arthropathies] 171
ARTROPATIE DISMETABOLICHE 171
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 170
Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application 170
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 170
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 169
Valore del dosaggio radioimmunologico del paratormone plasmatico nella diagnosi di iperparatiroidismo primitivo 168
DXA bone mineral density in males: retrospective study in real life. 167
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 167
[Relations between polycystic ovary and idiopathic hirsutism] 167
Circdian rhytm in serum PTH concentration in normal subjects and in primary hyperparathyroidoism: correlation with ionized serum calcium 167
Il dosaggio del calcio ionizzato nelle alterazioni del metabolismo fosfo-calcico 167
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 165
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 165
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 165
Sclerostin and DKK1 in primary hyperparathyroidism. 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 164
A morphometric ultrastructural study of unenvolved parathyroid glands in primary iperparathyroidism 164
Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism 163
Contributo allo studio del meccanismo d'azione ipouricemizzante del benziodarone 163
Totale 27.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 237.476
article - articoli 221.673
book - libri 0
conference - conferenze 7.846
curatela - curatele 0
other - altro 1.380
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.577
Totale 474.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.499 0 936 33 133 263 217 41 235 177 122 437 905
2022/20237.853 704 527 979 1.243 763 1.861 63 512 786 57 250 108
2023/20243.300 204 293 303 497 449 386 120 257 34 108 407 242
2024/20259.062 678 794 349 1.403 418 160 361 529 1.313 617 540 1.900
2025/202629.672 1.937 3.070 6.547 3.389 5.015 1.893 2.645 1.317 1.863 1.053 382 561
2026/2027685 349 336 0 0 0 0 0 0 0 0 0 0
Totale 79.259